Literature DB >> 6611507

Autoimmune human T lymphocytes specific for acetylcholine receptor.

R Hohlfeld, K V Toyka, K Heininger, H Grosse-Wilde, I Kalies.   

Abstract

Myasthenia gravis is one of the best characterized human autoimmune disorders. Circulating autoantibodies to the nicotinic acetylcholine receptor (AChR) at the neuromuscular junction play a prominent part in the effector phase, that is, the immunoregulation. Indirect evidence, such as thymic abnormalities and the association with certain histocompatibility antigens (for example HLA-B8,-DR3) suggests a defect of immunoregulation at the level of thymus-dependent (T) lymphocytes. We report here on the isolation of autoreactive T cells from six patients with myasthenia gravis. From one of these patients, who is homozygous for HLA-DR3, we established a long-term T-cell line. The line cells are specific for purified fish and human AChR, display the surface phenotype of inducer/helper T cells and are genetically restricted to HLA-DR3. AChR-induced proliferation could be inhibited with two monoclonal antibodies against monomorphic DR determinants and also with DR3-specific alloantiserum.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611507     DOI: 10.1038/310244a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  45 in total

Review 1.  Psychoneuroimmunology: potential relevance to chronic orofacial pain.

Authors:  S J Schleifer; J Marbach; S E Keller
Journal:  Anesth Prog       Date:  1990 Mar-Jun

2.  Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment.

Authors:  Andrea Fattorossi; Alessandra Battaglia; Alexia Buzzonetti; Francesca Ciaraffa; Giovanni Scambia; Amelia Evoli
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

3.  Antibodies to acetylcholine receptors in myasthenia gravis. In vitro synthesis by peripheral blood lymphocytes before and after thymectomy.

Authors:  J B Kuks; P C Limburg; H J Oosterhuis; T H The
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

4.  Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis.

Authors:  Y Li; V K Rauniyar; W F Yin; B Hu; S Ouyang; B Xiao; H Yang
Journal:  Neurol Sci       Date:  2013-05-26       Impact factor: 3.307

5.  Experimental autoimmune myasthenia gravis in the mouse.

Authors:  B Wu; E Goluszko; P Christadoss
Journal:  Curr Protoc Immunol       Date:  2001-05

6.  Phenotypic and functional characterization of T cells from patients with myasthenia gravis.

Authors:  F Mokhtarian; M Pino; W Ofosu-Appiah; D Grob
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

7.  Localized thymic amyloidosis presenting with myasthenia gravis: case report.

Authors:  Seung-Myoung Son; Yong-Moon Lee; Si Wook Kim; Ok-Jun Lee
Journal:  J Korean Med Sci       Date:  2013-12-26       Impact factor: 2.153

8.  High numbers of autoantigen-reactive mononuclear cells expressing interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) are present in cord blood.

Authors:  M Yu; S Fredrikson; J Link; H Link
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

9.  Presentation of endogenous acetylcholine receptor antigen to a specific CD4+ T-cell line by a transfected B-cell line.

Authors:  A F Mulcahy; D M Beeson; N Willcox; A G Diamond
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

10.  T helper cell recognition of muscle acetylcholine receptor in myasthenia gravis. Epitopes on the gamma and delta subunits.

Authors:  A A Manfredi; M P Protti; M W Dalton; J F Howard; B M Conti-Tronconi
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.